Future research could examine the relationship between blood cell parameters and neuropsychological outcomes alongside traditional markers of systemic and neuroinflammation, such as cytokines and translocator protein (TSPO), to help elucidate the mechanisms driving cognitive decline in people with aggressive lymphoma. This evidence concerns the gene TSPO and lymphoma.